Submit your papersSubmit Now
For Enquiries: [email protected]
IIARD LogoIIARD

Emerging Infectious Diseases and Global Health Security

Oyedeji Olugbenga James PhD & Ekaji Regina Morphy

Abstract

Emerging infectious diseases (EIDs) poses a growing threat to populations globally, it challenges healthcare systems, world economies, and social stability. These diseases, which often originates from animal to human transmission or genetic mutations, have caused significant outbreaks, such as SARS, Ebola and COVID 19, in the past decade. This article examines how EIDs impact global health security, it is a framework designed to protect humanity from threats from EIDs. The objective is to explore the epidemiology of EIDs, their risk factors and strategies to strengthen our preparation and response. This article draws on a comprehensive review of peer-reviewed literature, case studies of past outbreaks and expert opinions from public health sectors. Findings reveal that EIDs are driven by factors like climate change, globalization and urbanization, which accelerate disease spread. Weaknesses in our health care systems, such as inadequate surveillance and inequitable vaccine access, worsen the impact of EIDs. However, advancements in technology, including artificial intelligence for disease tracking and rapid diagnostic tools, offer hope for better control. The article also highlights the economic, social, and psychological consequences of pandemics, emphasizing the need for coordinated global action. In conclusion, EIDs demand a proactive approach to global health security. By strengthening surveillance networks, making investment in research for vaccines top priorities, diagnostics, and improving healthcare infrastructure, especially in low-income regions, are very critical steps to take. International collaboration and responsible communication are equally vital to fight misinformation and build trust into the mind of the general public. This article calls for sustained efforts to prepare for future outbreaks and it ensures that health systems are resilient and equitable. By addressing these challenges, we can reduce the de

Keywords

Emerging infectious diseases (EIDs)Global health securityHealthcare systemsAnimal-to-human transmissionGenetic mutationsOutbreaks (SARSEbolaCOVID-19)EpidemiologyRisk factorsClima

References

Brooks, S. K., Webster, R. K., Smith, L. E., Woodland, L., Wessely, S., Greenberg, N., & Rubin, G.J. (2020). The psychological impact of quarantine and how to reduce it: Rapid review of the evidence. The Lancet, 395(10227), 912-920. https://doi.org/10.1016/S0140- 6736(20)30460-8 Chua, K. B., Bellini, W. J., Rota, P. A., Harcourt, B. H., Tamin, A., Lam, S. K., ... Anderson, L. J. (2000). Nipah virus: A recently emergent deadly paramyxovirus. Science, 288(5470), 1432-1435. https://doi.org/10.1126/science.288.5470.1432 Coltart, C. E., Lindsey, B., Ghinai, I., Johnson, A. M., & Heymann, D. L. (2017). The Ebola outbreak, 2013–2016: Old lessons for new epidemics. Philosophical Transactions of the Royal Society B, 372(1721), 20160297. https://doi.org/10.1098/rstb.2016.0297 Fauci, A. S., Lane, H. C., & Redfield, R. R. (2020). Covid-19—Navigating the uncharted. New England Journal of Medicine, 382(13), 1268-1269. https://doi.org/10.1056/NEJMe2002387 Flaxman, S., Mishra, S., Gandy, A., Unwin, H. J. T., Mellan, T. A., Coupland, H., ... Bhatt, S. (2020). Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature, 584(7820), 257-261. https://doi.org/10.1038/s41586-020-2405-7 Gandhi, N. R., Nunn, P., Dheda, K., Schaaf, H. S., Zignol, M., van Soolingen, D., ... Bayona, J. (2010). Multidrug-resistant and extensively drug-resistant tuberculosis: A threat to global control of tuberculosis. The Lancet, 375(9728), 1830-1843. https://doi.org/10.1016/S0140- 6736(10)60410-2 Gostin, L. O., & Katz, R. (2016). The International Health Regulations: The governing framework for global health security. Milbank Quarterly, 94(2), 264-313. https://doi.org/10.1111/1468-0009.12186 Heymann, D. L., & Rodier, G. (2004). Global surveillance, national surveillance, and SARS. Emerging Infectious Diseases, 10(2), 173-175. https://doi.org/10.3201/eid1002.031038 International Monetary Fund. (2021). World Economic Outlook: Managing divergent recoveries. IMF. https://www.imf.org/en/Publications/WEO Jones, K. E., Patel, N. G., Levy, M. A., Storeygard, A., Balk, D., Gittleman, J. L., & Daszak, P. (2008). Global trends in emerging infectious diseases. Nature, 451(7181), 990-993. https://doi.org/10.1038/nature06536 Khan, K., Arino, J., Hu, W., Raposo, P., Sears, J., Calderon, F., ... Gardam, M. (2009). Spread of a novel influenza A (H1N1) virus via global airline transportation. New England Journal of Medicine, 361(2), 212-214. https://doi.org/10.1056/NEJMc0904559 Larson, H. J. (2018). The biggest pandemic risk? Viral misinformation. Nature, 562(7727), 309. https://doi.org/10.1038/d41586-018-07034-4 Lee, S. M., Kang, W. S., Cho, A. R., Kim, T., & Park, J. K. (2021). South Korea’s response to COVID-19: Lessons from a success story. Health Policy, 125(10), 1285-1290. https://doi.org/10.1016/j.healthpol.2021.07.003 Leroy, E. M., Kumulungui, B., Pourrut, X., Rouquet, P., Hassanin, A., Yaba, P., ... Swanepoel, R. (2005). Fruit bats as reservoirs of Ebola virus. Nature, 438(7068), 575-576. https://doi.org/10.1038/438575a Li, W., Shi, Z., Yu, M., Ren, W., Smith, C., Epstein, J. H., ... Zhang, J. (2005). Bats are natural reservoirs of SARS-like coronaviruses. Science, 310(5748), 676-679. https://doi.org/10.1126/science.1118391 Mackenzie, J. S., Drury, P., Ellis, A., Grein, T., Leitmeyer, K. C., & Mardel, S. (2014). The WHO response to SARS and preparations for the future. The Lancet, 383(9927), 1465-1467. https://doi.org/10.1016/S0140-6736(14)60592-5 Madhav, N., Oppenheim, B., Gallivan, M., Mulembakani, P., Rubin, E., & Wolfe, N. (2017). Pandemics: Risks, impacts, and mitigation. In Disease control priorities (3rd ed., Vol. 9, pp. 315-345). World Bank. Mathieu, E., Ritchie, H., Ortiz-Ospina, E., Roser, M., Hasell, J., Appel, C., ... Rodés-Guirao, L. (2021). A global database of COVID-19 vaccinations. Nature Human Behaviour, 5(7), 947-953. https://doi.org/10.1038/s41562-021-01122-8 Morens, D. M., Folkers, G. K., & Fauci, A. S. (2004). The challenge of emerging and re-emerging infectious diseases. Nature, 430(6996), 242-249. https://doi.org/10.1038/nature02759 Olsen, S. J., Chang, H. L., Cheung, T. Y., Tang, A. F., Fisk, T. L., Ooi, S. P., ... Lando, J. (2020). Transmission of the severe acute respiratory syndrome on aircraft. New England Journal of Medicine, 349(25), 2416-2422. https://doi.org/10.1056/NEJMoa031349 Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018). mRNA vaccines—A new era in vaccinology. Nature Reviews Drug Discovery, 17(4), 261-279. https://doi.org/10.1038/nrd.2017.243 Plante, J. A., Liu, Y., Liu, J., Xia, H., Johnson, B. A., Lokugamage, K. G., ... Shi, P. Y. (2021). Spike mutation D614G alters SARS-CoV-2 fitness. Nature, 592(7852), 116-121. https://doi.org/10.1038/s41586-020-2895-3 Roca, A., Afolabi, M. O., Saidu, Y., & Kampmann, B. (2015). Ebola: A call to action—The importance of research in epidemics. The Lancet, 385(9965), 424-425. https://doi.org/10.1016/S0140-6736(14)62345-8 Wang, C. J., Ng, C. Y., & Brook, R. H. (2020). Response to COVID-19 in Taiwan: Big data analytics, new technology, and proactive testing. JAMA, 323(14), 1341-1342. https://doi.org/10.1001/jama.2020.3151 Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M., & Kawaoka, Y. (1992). Evolution and ecology of influenza A viruses. Microbiological Reviews, 56(1), 152-179. https://doi.org/10.1128/mr.56.1.152-179.1992 Woolhouse, M. E., & Gowtage-Sequeria, S. (2005). Host range and emerging and reemerging pathogens. Emerging Infectious Diseases, 11(12), 1842-1847. https://doi.org/10.3201/eid1112.050997 World Health Organization. (2020). Global spending on health: A world in transition. WHO. https://www.who.int/publications/i/item/global-spending-on-health-a-world-in-transition World Health Organization. (2021). Global health security: Towards a safer world. WHO. https://www.who.int/health-topics/health-security Brennen, J. S., Simon, F. M., Howard, P. N., & Nielsen, R. K. (2020). Types, sources, and claims of COVID-19 misinformation. Reuters Institute for the Study of Journalism. https://reutersinstitute.politics.ox.ac.uk/types-sources-and-claims-covid-19- misinformation Roozenbeek, J., Schneider, C. R., Dryhurst, S., Kerr, J., Freeman, A. L. J., Recchia, G., ... van der Linden, S. (2020). Susceptibility to misinformation about COVID-19 around the world. Royal Society Open Science, 7(10), 201199. https://doi.org/10.1098/rsos.201199 Dubé, E., Laberge, C., Guay, M., Bramadat, P., Roy, R., & Bettinger, J. A. (2015). Vaccine hesitancy: An overview. Human Vaccines & Immunotherapeutics, 9(8), 1763-1773. https://doi.org/10.4161/hv.24657 Wilson, S. (2020). Pandemic leadership: Lessons from New Zealand’s approach to COVID-19. Leadership, 16(3), 279-293. https://doi.org/10.1177/1742715020929151 Vraga, E. K., & Bode, L. (2017). Using expert sources to correct health misinformation in social media. Science Communication, 39(5), 621-645. https://doi.org/10.1177/1075547017731776 Ghinai, I., Willott, C., Dadari, I., & Larson, H. J. (2013). Listening to the rumours: What the northern Nigeria polio vaccine boycott can tell us ten years on. Global Public Health, 8(10), 1138-1150. https://doi.org/10.1080/17441692.2013.859720 Wilkinson, A., & Leach, M. (2015). Briefing: Ebola—Myths, realities, and structural violence. African Affairs, 114(454), 136-148. https://doi.org/10.1093/afraf/adu080 Larson, H. J., Jarrett, C., Eckersberger, E., Smith, D. M. D., & Paterson, P. (2014). Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012. Vaccine, 32(19), 2150-2159. https://doi.org/10.1016/j.vaccine.2014.01.081 Broadhurst, M. J., Brooks, T. J. G., & Pollock, N. R. (2016). Diagnosis of Ebola virus disease: Past, present, and fu